Hereditary Elliptocytosis Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Hereditary Elliptocytosis
Hereditary elliptocytosis is a genetic blood disorder characterized by abnormally shaped red blood cells, which can lead to anemia and other health issues. While symptoms vary, managing the condition often involves ongoing medical care and prescription medications. TheDrugClub helps individuals and families afford these essential treatments, making health management more accessible and less financially burdensome.
Hereditary elliptocytosis (HE) is a group of inherited blood disorders affecting the shape of red blood cells. Instead of the typical round, biconcave disc, red blood cells in individuals with HE are oval or elliptical. This abnormal shape makes them less flexible and more fragile, leading to their premature destruction in the spleen, a process known as hemolysis. The condition is caused by mutations in genes that produce proteins vital for maintaining the red blood cell membrane's structure, such as *SPTA1*, *SPTB*, and *EPB41*.
The severity of HE varies widely. Many individuals with HE are asymptomatic or experience only mild anemia, requiring no specific treatment. However, more severe forms can lead to chronic anemia, jaundice (yellowing of the skin and eyes), an enlarged spleen (splenomegaly), and gallstones. Diagnosis typically involves a blood smear to observe the distinctive elliptical red blood cells, along with other blood tests to assess anemia and hemolysis. Genetic testing can confirm the specific mutation.
For those who do require treatment, common approaches focus on managing symptoms and preventing complications. Folic acid supplementation is often prescribed to support increased red blood cell production, especially in cases of chronic hemolysis. Blood transfusions may be necessary for severe anemia. In more serious cases, a splenectomy (surgical removal of the spleen) can significantly reduce red blood cell destruction and improve anemia, though it carries its own risks. Iron chelation therapy might be needed if frequent transfusions lead to iron overload. Medications to manage pain or gallstone formation may
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.